20/20 Biolabs Common Stock Overview

20/20 Biolabs Common Stock Total Revenue

Revenue analysis for AIDX.

Quarterly Revenue

$353375.00

As of Mar 2026

Annual Revenue (TTM)

$1.67M

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin